0 followers
We’re reducing the barriers to the development of better treatments for common diseases by combining smart randomized trial design with effective technology and collaborative partnerships.
Sir Martin Landray
Queen Mary University
5 followers
Etiqa
1 follower
The Academy of Medical Sciences
1 follower
Genomics England
3 followers
Flyer One Ventures
1 follower
Signum Biosciences
1 follower
Eupry
4 followers
Otsuka Pharmaceutical Companies Europe
5 followers
Diligenta - a subsidiary of Tata Consultancy Services
3 followers
Research Partnership
1 follower
RTW Investments LLC
1 follower
Explore companies